Glenmark Pharmaceuticals Fundamental Analysis
GLENMARK
2166.631.90 (-1.45%)
Last updated on 23 Oct, 2026 | 15:56 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
34.27
P/B Ratio
5.62
Div. Yield
0.11
Sector P/E
38.79
Sector P/B
3.22
Sec. Div. Yield
0.53
Glenmark Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 34.27, compared to the sector average of 38.79. Its P/B Ratio stands at 5.62, while the sector’s is 3.22. In terms of returns, the stock offers a Dividend Yield of 0.11%, which is than the sector’s 0.53%.
Glenmark Pharmaceuticals Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Average
On its scorecard, Glenmark Pharmaceuticals reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
Glenmark Pharmaceuticals Associated Pages
- Glenmark Pharmaceuticals
Share Price - Glenmark Pharmaceuticals
Share Price chart - Glenmark Pharmaceuticals
Technical Analysis - Glenmark Pharmaceuticals
Peer Comparison - Glenmark Pharmaceuticals
Share Price History - Glenmark Pharmaceuticals
Dividend - Glenmark Pharmaceuticals
Board of Directors - Glenmark Pharmaceuticals
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GLENMARK
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC